Genedata (Usa), Inc.
Lexington, MA
- UEI
- DNC7SYWFNYH7
- CAGE
- 38ME5
- Primary NAICS
- 513210 Software Publishers
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 1 Cranberry Hill #403, Lexington, MA 02421, USA
- Website
- genedata.com
- Founded
- 1997
- Employees
- 251-1K
- Estimated annual revenue
- $50M-$100M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $94,080 |
| FY2025 | $100,075 |
| FY2024 | $84,900 |
| FY2023 | $78,409 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Defense Health Agency | $68,180 | |
| 2 | Department of Health and Human Services | $25,900 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Graphpad Software, LLC | Boston, MA | 513210 Software Publishers |
| Gene Codes Corp | Ann Arbor, MI | 513210 Software Publishers |
| Sentieon Inc. | San Jose, CA | 513210 Software Publishers |
| GSL Biotech, LLC | — | 513210 Software Publishers |
| Dnastar, Inc. | Madison, WI | 513210 Software Publishers |
About the company
Genedata (Usa), Inc., a for-profit software corporation based in Lexington, Massachusetts, supplies bioinformatics and laboratory data-analysis software to federal research institutions and the Department of Defense on a prime-contractor basis, operating exclusively in full-and-open procurement and sole-source awards with no set-aside participation. The vendor is self-certified as a small disadvantaged business in SAM.gov and has held federal awards continuously since 2007.
Genedata's core product portfolio centers on two flagship bioinformatics platforms: Genedata Analyst and Genedata Screener. Genedata Analyst is a statistical modeling and multi-omics visualization suite used by the National Institute of Allergy and Infectious Diseases' Viral Pathogenesis and Evolution Section for normalization, parametric and non-parametric statistical testing, principal components analysis, mixed linear models, machine learning, and interactive visualization (heat maps, scatter plots, specialized statistical viewers) of gene expression, transcriptomics, and proteomics data derived from vaccine and infection studies. Genedata Screener is a specialized platform designed to analyze data from Opera Imaging instruments, providing database exploration and analyzer functionality for research operations. All awards are sole-source, reflecting Genedata's status as the sole manufacturer and distributor of these proprietary software products. Recent representative awards include a $353,440 firm fixed-price purchase order from the Defense Health Agency on September 15, 2024, for Genedata Screener licensing, maintenance, and support running through September 2029; a $25,900 purchase order from NIAID on September 22, 2026, for Genedata Analyst renewal; and a $25,900 purchase order from NIAID on March 1, 2025, for Analyst license, maintenance, and support.
Customer concentration is dominated by two federal agencies. The National Institute of Allergy and Infectious Diseases (part of the National Institutes of Health) holds 11 awards totaling $263 thousand combined potential value (covering 50% of awards by count but only 16% of dollars), while the Defense Health Agency holds 2 awards totaling $684 thousand combined potential value (12% of awards but 41% of dollars). The Department of the Army Medical Command (5 awards, $453 thousand) ranks third. These three agencies account for 95% of recent awards and 97% of combined potential value. Activity has remained modest and flat—one award per year in 2023, 2025, and 2026, two in 2024—with a combined portfolio of 22 awards totaling $1.6 million in potential value and $1.4 million obligated. Only one award ($26 thousand) reaches ultimate completion within the next twenty-four months, presenting minimal recompete exposure. The vendor operates exclusively as a prime contractor (100% of awards); no subcontract activity is present in the source data.
Quick answers
Is Genedata (Usa), Inc. registered in SAM.gov?
Yes. Genedata (Usa), Inc.'s SAM.gov registration is active through August 17, 2027.
How much has Genedata (Usa), Inc. received in federal contracts?
Federal contracts obligated $100,075 to Genedata (Usa), Inc. in fiscal year 2025 and $357,464 in fiscal years 2023 through 2027.
What is Genedata (Usa), Inc.'s most recent federal award?
Genedata (Usa), Inc.'s most recent federal contract award is NIH niaid genedata analyst bioinformatics software program (7571TE26P00137), from Assistant Secretary for Financial Resources, on September 22, 2026.
On GovTribe
See Genedata (Usa), Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors